Loading...
OTCM
CTGL
Market cap208mUSD
Dec 05, Last price  
0.20USD
1D
-9.00%
1Q
900.50%
Jan 2017
-59.58%
IPO
-95.49%
Name

Citrine Global Corp

Chart & Performance

D1W1MN
OTCM:CTGL chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
99.60%
Rev. gr., 5y
-15.66%
Revenues
0k
P
092,9085,8165,8005,8245,84800251,417149,08511,372-52,000-24,0000
Net income
-2m
L-30.45%
-14,302-70,599-349,145-1,445,529-4,365,589-1,533,589-1,853,722-2,858,390-2,157,074-1,912,522-8,289,401-4,059,000-3,304,000-2,298,000
CFO
-4k
L-99.29%
-8,1186,866-175,755-352,942-1,806,298-1,029,288-1,290,231-1,470,395-2,386,436-1,225,577-696,033-582,000-567,000-4,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Citrine Global Corp. operates as a plant-based wellness and pharma solutions company. It focuses on developing plant-based products to enhance quality of life, and complementary solutions for balancing side effects caused by using medicines, cannabis, treatments, or an unbalanced lifestyle. The company was formerly known as TechCare Corp. and changed its name to Citrine Global Corp. in August 2020. Citrine Global Corp. was incorporated in 2010 and is headquartered in Herzliya, Israel.
IPO date
Jun 01, 2010
Employees
18
Domiciled in
IL
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT